Codex DNA (NASDAQ:DNAY) Downgraded by Zacks Investment Research to Hold

Codex DNA} stock has undergone multiple analysts rating changes in the recent past.  Codex DNA Downgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Codex DNA (NASDAQ:DNAY) Downgraded by Zacks Investment Research to Hold